Paul Romness

May 18, 2025

From Biotech Startup to Stock Market | Paul Romness, MHA, Health Policy OS Therapies, CEO

Can a small biotech change cancer care—and turn a profit? Paul Romness, CEO of OS Therapies, shares how his five-person team took on one of the deadliest pediatric cancers, went public, and might just shake up the system. Fro...

Guest: Paul Romness